Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1995-10-27
|
| pubmed:abstractText |
Cardiac amyloidosis has a poor prognosis, with a median survival of approximately 6 months once symptoms develop. This patient had a markedly improved quality of life with cardiac transplantation. We would suggest that with refinement of pretransplant chemotherapy, prolonged survival may be possible in carefully selected cases.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0002-9149
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
76
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
739-41
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7572642-Amyloidosis,
pubmed-meshheading:7572642-Cardiomyopathies,
pubmed-meshheading:7572642-Echocardiography,
pubmed-meshheading:7572642-Female,
pubmed-meshheading:7572642-Heart Transplantation,
pubmed-meshheading:7572642-Humans,
pubmed-meshheading:7572642-Middle Aged,
pubmed-meshheading:7572642-Recurrence,
pubmed-meshheading:7572642-Survivors
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival.
|
| pubmed:affiliation |
Division of Cardiology, Boston University School of Medicine, Massachusetts 02118, USA.
|
| pubmed:publicationType |
Journal Article,
Case Reports
|